Ann-Charlotte Bentley to Neuroprotective Agents
This is a "connection" page, showing publications Ann-Charlotte Bentley has written about Neuroprotective Agents.
Connection Strength
0.423
-
Nerve growth factor in treatment and pathogenesis of Alzheimer's disease. Prog Neurobiol. 2006 Oct; 80(3):114-28.
Score: 0.108
-
Estrogen alters amyloid precursor protein as well as dendritic and cholinergic markers in a mouse model of Down syndrome. Hippocampus. 2003; 13(8):905-14.
Score: 0.083
-
Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model. Exp Neurol. 2009 Apr; 216(2):278-89.
Score: 0.063
-
Behavioral and morphological effects of minocycline in the 6-hydroxydopamine rat model of Parkinson's disease. Brain Res. 2006 Jun 06; 1093(1):198-207.
Score: 0.052
-
Behavioral and neurobiological markers of Alzheimer's disease in Ts65Dn mice: effects of estrogen. Neurobiol Aging. 2004 Aug; 25(7):873-84.
Score: 0.046
-
Minocycline protects basal forebrain cholinergic neurons from mu p75-saporin immunotoxic lesioning. Eur J Neurosci. 2004 Jun; 19(12):3305-16.
Score: 0.046
-
BDNF levels are increased by aminoindan and rasagiline in a double lesion model of Parkinson?s disease. Brain Res. 2016 Jan 15; 1631:34-45.
Score: 0.025